Ace inhibitors in macular degeneration

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 7, 514 9, 514213, 514221, 514250, 514259, 514310, 514419, 514490, 514562, 514912, A61K 31195, A61K 3140, A61K 3127, A61K 31505

Patent

active

046561889

ABSTRACT:
Angiotensin converting enzyme inhibitors are useful in the treatment of senile macular degeneration.

REFERENCES:
patent: 3995057 (1976-11-01), Horrmann
patent: 4046889 (1977-09-01), Ondetti et al.
Igic and Kojovic, Exp. Eye Res., 30, 299-303 (1980).
Chem. Abst. 74:91148w (1971)--Dabis.
Chem. Abst. 96:210615n (1982)--Toshimoto et al.
Chem. Abst. 99:47727b (1983)--Yamagami et al.
Chem. Abst. 101:177530c (1984)--Watkins et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Ace inhibitors in macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ace inhibitors in macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ace inhibitors in macular degeneration will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1087128

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.